A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2002
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449077A1 Epothilone derivatives
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002	CA2448656A1 Compositions and methods for inhibiting bone resorption
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2446929A1 Orally administering parathyroid hormone and calcitonin
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263978A2 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263933A2 Treatment for bone disorders
12/11/2002	EP1263929A2 Artificial bone chips, methods for the production thereof and their use
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263719A1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263463A1 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cells
12/11/2002	EP1263459A2 Attenuation of fibroblast proliferation
12/11/2002	EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
12/11/2002	EP1263444A2 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263418A2 Cartilage enhancing food supplements and methods of preparing the same
12/11/2002	EP1100805B1 Medicine nitrate salts
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0937062B1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0937060B1 Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/11/2002	CN1384749A Use of diphophonic acid in treatment of vasculogenesis
12/11/2002	CN1384733A Dry powder compositions having improved dispersivity
12/11/2002	CN1384713A Dietary food supplement containing natural cyclooxygenase inhibitors
12/11/2002	CN1383882A Ointment for relaxing muscles and joints and promoting blood circulation
12/11/2002	CN1383869A Ointment for healing tranumatic injury fast
12/11/2002	CN1383853A Rheuamtism treating Chinese medicine
12/11/2002	CN1383842A Chinese mediicne plaster for treating hyperosteogeny
12/11/2002	CN1383836A Medicine for treating hyperosteogeny in cervical vertebra and lumbar vertebra
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CN1095675C Medicinal plaster for curing wind-cold-dampness pathogen and traumatic injury
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492429 Apocynin and an inhibitor of inducible nitric oxide synthase
12/10/2002	US6492428 Macrophage migration inhibitory factor (mif); substituted iminoquinone or orthoquinone ring systems
12/10/2002	US6492425 Inhibitors of transcription factor-NF-κB
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492403 Methods of treating C1s-mediated diseases and conditions and compositions thereof
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492356 Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492353 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs
12/10/2002	US6492333 Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF
12/05/2002	WO2002097060A2 Carbohydrate-associated proteins
12/05/2002	WO2002097046A2 B7 related protein-2 molecules and uses thereof
12/05/2002	WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	WO2002097032A2 Proteins associated with cell growth, differentiation, and death
12/05/2002	WO2002097030A2 Peptides derived from neural thread proteins and their medical use
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096927A2 Ribozyme based treatment of female reproductive diseases

1 ... 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 ... 820